Jason Haddock, CFO at ARRAY BIOPHARMA INC (ARRY), sold 96,712 shares at $20.00 ($2.1M) on 2019-02-06, disclosed to the SEC on 2019-02-08.
Open-market sale of $2.1M ARRY by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 11,712 | $234K | 11.1% |
| 2 | $22.05 | 85,000 | $1.9M | 88.9% |
| Total | $21.80 avg | 96,712 | $2.1M | 100% |
| Filing → |
| ARRY | SELL | 2018-01-16 | $103K | — | Filing → |